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Lee A.H.Y., Busby J., Brooks M., Hollingworth W. Eur J Vasc Endovasc
Surg 2013;46:282-9.
Objective: We report the uptake, length of stay and vascular readmis-
sion rates of carotid endarterectomy (CEA) and CAS among patients with
symptomatic or asymptomatic carotid artery disease in the English National
Health Service (NHS).
Methods: Retrospective cohort study based on routinely collected
Hospital Episode Statistics (HES) inpatient data. We identiﬁed individual
admissions for CEA (n = 15996) or CAS (n = 632) between 2006 and
2009. Summary data were used to describe procedure volumes between
2009 and 2012.We analysed trends in procedure use over time and used ordi-
nary least squares regression to evaluate patient, clinical and organisational
characteristics associated with longer length of stay for revascularisation.
Results: CAS made up less than 5% of carotid revascularisation proce-
dures; there was no trend for increasing use between 2006 and 2012.
Patients treated with CAS were on average younger, lived in areas of higher
deprivation and were more likely to have amaurosis fugax or a comorbidity
of heart disease. CAS patients had a 19% (95% CI 14-24) shorter stay in
hospital than CEA patients.
Conclusion: Despite the early promise of CAS and numerous rando-
mised controlled trials evaluating efﬁcacy, it has not been rapidly adopted in
England. Cautious adoption may be appropriate given the higher periproce-
dural risk of stroke or death after CAS, particularly in recently symptomatic
patients.
Common Carotid Artery Occlusion Treatment: Revealing a Gap in the
Current Guidelines
Klonaris C., Kouvelos G.N., Kafeza M., Koutsoumpelis A., Katsargyris A.,
Tsigris C. Eur J Vasc Endovasc Surg 2013;46:291-8.
Objective: To review the literature on the management of common
carotid artery occlusion (CCAO).
Methods: A review of English-language medical literature from 1965
to 2012 was conducted using the PubMed and EMBASE databases to ﬁnd
all studies involving management of CCAO. The search identiﬁed 21 articles
encompassing 146 patients/arteries (73.2% men; mean age 65 6 6.9 years).
Results: The majority of the patients (93.8%) were symptomatic. Most
of the patients (61.5%) had ipsilateral internal carotid artery (ICA) and
external carotid artery (ECA) patent, while an occluded ICA and a patent
ECA were found in 26.6% of the patients. Eighty per cent of the patients
treated underwent a surgical bypass procedure, with the subclavian artery as
themost common inﬂow vessel (64.1%).During the ﬁrst 30 days of the proce-
dure two strokes (1.5%) were reported. During a follow-up period spanning
an average of 25.66 11.2 months nine patients (6.6%) experienced a clinical
cerebrovascular event. Seven restenoses (5.1%) and two reocclusions (1.5%)
also occurred-eight after open surgical and one after endovascular repair.
Conclusion: The necessity to intervene to a CCAO remains contro-
versial. This review shows that open surgical management of symptomatic
CCA occlusive disease is a safe, durable, and effective therapeutic strategy
with low perioperative cerebrovascular morbidity.
A 14-year Experience with Aortic Endograft Infection: Management
and Results
Lyons O.T.A., Patel A.S., Saha P., Clough R.E., Price N., Taylor P.R. Eur J
Vasc Endovasc Surg 2013;46:306-13.
Objectives: The management of thoracic and abdominal aortic
endograft infection is complex and associated with high mortality. Cases
are rare: a recent systematic review identiﬁed 117 reported cases; the largest
reported series comprises 12 infected endografts.
Methods: We report 22 consecutive patients with infected abdominal
or thoracic aortic endovascular devices implanted from 1998 to 2012.846Management included extension with new devices, aneurysm sac drainage
of pus/irrigation with antibiotics, endograft explantation, and axillo-(bi)
femoral reconstruction.
Results: Twenty-two patients (16 men) were identiﬁed. Median age
was 71 years (range, 43-88 years). Index devices were infra-renal endovas-
cular repair (n = 13), and thoracic endovascular repair (n = 9) all for aneu-
rysmal or pseudoaneurysmal disease. Seven (32%) had prior aortic surgery.
Follow-up was complete in all cases; in survivors follow-up was a median
of 29 (range, 12-45) months. The mortality from explantation of ten
infra-renal devices was 1/10 (10%) on-table and a further 2/10 (20%)
within 30 days. Device retention led to disease progression and death in
all patients with infected endografts. Sac drainage/irrigation provided
only temporary control of sepsis. Device extension can treat rupture, but
additional devices became infected.
Conclusion: Abdominal endograft explantation is high risk but may
be curative. Appropriate selection of patients for infected endograft explan-
tation remains a major challenge.
Mid-termResults of Endovascular Aortic AneurysmRepair in the Young
Altaf N., Abisi S., Yong Y., Saunders J.H., Braithwaite B.D., MacSweeney S.T.
Eur J Vasc Endovasc Surg 2013;46:315-9.
Objectives: To compare the mid-term outcome and secondary inter-
vention rate following elective open and endovascular aortic aneurysm
repair (EVAR) in patients aged 65 years and younger.
Methods: A retrospective analysis of patients aged 65 years and
younger who had elective abdominal aortic aneurysm repair (AAA) between
1994 and 2012.
Results: One hundred and sixty-ﬁve patients under the age of 65
years (mean age: 61 years 6 4; 8 women) had elective abdominal aneurysm
repair (97 EVAR and 68 open). The overall 30-day mortality rate was 3.7%
(2.1% EVAR and 5.9% open). Forty per cent of patients had died at a median
follow up of 77 months (interquartile range, 36-140). Most deaths were not
related to aneurysm. There was no difference in the long-term mortality
between the EVAR and open groups (hazard ratio [HR] = 1.22; 95% conﬁ-
dence interval [CI] 0.75-1.98, P = .43), but there was a trend of better
outcomes with the use of commercially made endografts over open repair
(HR = 2.9; 95% CI 0.9-10.0, P = .08) and custom-made endografts
(HR = 3.1, 95% CI 0.9-10.3; P = .07). Eleven per cent of patients who
had EVAR required a further procedure compared with 13% who had
open repair. All but one of the re-interventions in the EVAR group was per-
formed on patients who had custom-made endografts.
Conclusions: Young patients with AAA have signiﬁcant comorbid-
ities and do not necessarily have long lifespans. In the less ﬁt younger
patients with AAA, the results with EVAR are comparable with ﬁt patients
who had open AAA repair. The management of ﬁtter young patients with
AAA remains controversial, but improving results with EVAR over time
may increase the role of EVAR in this group.
Diagnostic Performance of Computed Tomography Angiography in
Peripheral Arterial Injury due to Trauma: A Systematic Review and
Meta-analysis
Jens S., Kerstens M.K., Legemate D.A., Reekers J.A., Bipat S.,
Koelemay M.J.W. Eur J Vasc Endovasc Surg 2013;46:329-37.
Objectives: To evaluate the diagnostic accuracy of computed tomog-
raphy angiography (CTA) in detecting arterial lesions in patients with sus-
pected arterial injury of the upper or lower extremity due to trauma.
Methods: A systematic review and meta-analysis was carried out. Med-
line and Embase were searched on August 13, 2012, for studies comparing
CTA with surgery, digital subtraction angiography (DSA), or follow-up,
which allowed extraction of data into two-by-two tables. Themethodological
quality of included studies was assessed using the QUADAS tool. Summary
estimates of sensitivity and speciﬁcity of CTA in identifying or excluding arte-
rial lesions were obtained using a bivariate model.
